nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—Toremifene—ESR1—osteoarthritis	0.00529	0.715	CrCbGaD
Loperamide—Tamoxifen—ESR1—osteoarthritis	0.00211	0.285	CrCbGaD
Loperamide—CALM2—Disease—TGFBI—osteoarthritis	0.000497	0.000501	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—PTGS2—osteoarthritis	0.000492	0.000495	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—FMOD—osteoarthritis	0.000491	0.000495	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MCF2L—osteoarthritis	0.000483	0.000486	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IHH—osteoarthritis	0.000483	0.000486	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000482	0.000486	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MCF2L—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IHH—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IHH—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MCF2L—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000467	0.00047	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000463	0.000466	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CXCL8—osteoarthritis	0.000461	0.000465	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000459	0.000463	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—IL6—osteoarthritis	0.000455	0.000459	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—BMP2—osteoarthritis	0.000451	0.000454	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CXCL8—osteoarthritis	0.000448	0.000451	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—MMP3—osteoarthritis	0.000447	0.00045	CbGpPWpGaD
Loperamide—CALM3—Disease—GSTO1—osteoarthritis	0.000444	0.000448	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—IL6—osteoarthritis	0.000441	0.000444	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—IL6—osteoarthritis	0.000441	0.000444	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—IL6—osteoarthritis	0.000439	0.000442	CbGpPWpGaD
Loperamide—CALM3—Disease—BGN—osteoarthritis	0.00043	0.000433	CbGpPWpGaD
Loperamide—CALM2—Disease—GSTO1—osteoarthritis	0.00043	0.000433	CbGpPWpGaD
Loperamide—CALM1—Disease—GSTO1—osteoarthritis	0.00043	0.000433	CbGpPWpGaD
Loperamide—CALM3—Immune System—CTSK—osteoarthritis	0.000429	0.000432	CbGpPWpGaD
Loperamide—CALM3—Immune System—CAMK2B—osteoarthritis	0.000429	0.000432	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000422	0.000425	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP9—osteoarthritis	0.000417	0.00042	CbGpPWpGaD
Loperamide—CALM2—Disease—BGN—osteoarthritis	0.000416	0.000419	CbGpPWpGaD
Loperamide—CALM1—Disease—BGN—osteoarthritis	0.000416	0.000419	CbGpPWpGaD
Loperamide—CALM2—Immune System—CTSK—osteoarthritis	0.000415	0.000418	CbGpPWpGaD
Loperamide—CALM1—Immune System—CTSK—osteoarthritis	0.000415	0.000418	CbGpPWpGaD
Loperamide—CALM2—Immune System—CAMK2B—osteoarthritis	0.000415	0.000418	CbGpPWpGaD
Loperamide—CALM1—Immune System—CAMK2B—osteoarthritis	0.000415	0.000418	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGES—osteoarthritis	0.0004	0.000403	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—MMP1—osteoarthritis	0.000385	0.000388	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GSTO1—osteoarthritis	0.000382	0.000385	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—BMP2—osteoarthritis	0.000381	0.000384	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000377	0.00038	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—MMP1—osteoarthritis	0.000373	0.000376	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—MMP1—osteoarthritis	0.000373	0.000376	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GSTO1—osteoarthritis	0.000372	0.000375	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—BGN—osteoarthritis	0.00037	0.000373	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.00037	0.000373	CbGpPWpGaD
Loperamide—CALM3—Metabolism—BGN—osteoarthritis	0.00036	0.000363	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GSTO1—osteoarthritis	0.00036	0.000363	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GSTO1—osteoarthritis	0.00036	0.000363	CbGpPWpGaD
Loperamide—CALM3—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.000359	0.000361	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000358	0.000361	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000358	0.000361	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000358	0.000361	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP3—osteoarthritis	0.000356	0.000359	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—COL9A2—osteoarthritis	0.000354	0.000357	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—FN1—osteoarthritis	0.000352	0.000354	CbGpPWpGaD
Loperamide—CALM1—Metabolism—BGN—osteoarthritis	0.000349	0.000351	CbGpPWpGaD
Loperamide—CALM2—Metabolism—BGN—osteoarthritis	0.000349	0.000351	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—IL6—osteoarthritis	0.000348	0.000351	CbGpPWpGaD
Loperamide—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.000347	0.00035	CbGpPWpGaD
Loperamide—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.000347	0.00035	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000347	0.000349	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000347	0.000349	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—IL6—osteoarthritis	0.000346	0.000349	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—IL6—osteoarthritis	0.000344	0.000347	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TGFB1—osteoarthritis	0.000344	0.000347	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—COL9A1—osteoarthritis	0.000344	0.000347	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CRP—osteoarthritis	0.000343	0.000346	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—IL6—osteoarthritis	0.000343	0.000345	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—COL9A2—osteoarthritis	0.000343	0.000345	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—COL9A2—osteoarthritis	0.000343	0.000345	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000341	0.000344	CbGpPWpGaD
Loperamide—CALM3—Immune System—HSPA5—osteoarthritis	0.000341	0.000344	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—FN1—osteoarthritis	0.00034	0.000343	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—FN1—osteoarthritis	0.00034	0.000343	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—IL6—osteoarthritis	0.000337	0.000339	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—IL6—osteoarthritis	0.000337	0.000339	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—IL6—osteoarthritis	0.000335	0.000337	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—IL6—osteoarthritis	0.000335	0.000337	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—IL6—osteoarthritis	0.000333	0.000336	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—IL6—osteoarthritis	0.000333	0.000336	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—COL9A1—osteoarthritis	0.000333	0.000335	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—COL9A1—osteoarthritis	0.000333	0.000335	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1RN—osteoarthritis	0.000332	0.000335	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CRP—osteoarthritis	0.000332	0.000334	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CRP—osteoarthritis	0.000332	0.000334	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—IL6—osteoarthritis	0.000332	0.000334	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—IL6—osteoarthritis	0.000332	0.000334	CbGpPWpGaD
Loperamide—CALM2—Immune System—HSPA5—osteoarthritis	0.00033	0.000333	CbGpPWpGaD
Loperamide—CALM1—Immune System—HSPA5—osteoarthritis	0.00033	0.000333	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000324	0.000326	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—IL6—osteoarthritis	0.000323	0.000325	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—IL6—osteoarthritis	0.000323	0.000325	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000323	0.000325	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SMAD3—osteoarthritis	0.000322	0.000325	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1RN—osteoarthritis	0.000321	0.000324	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1RN—osteoarthritis	0.000321	0.000324	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—IL6—osteoarthritis	0.00032	0.000322	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000317	0.000319	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—IL6—osteoarthritis	0.000315	0.000318	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—BGN—osteoarthritis	0.000313	0.000316	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP3—osteoarthritis	0.000312	0.000315	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—IL6—osteoarthritis	0.000312	0.000314	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CXCL8—osteoarthritis	0.00031	0.000312	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—IL6—osteoarthritis	0.000309	0.000312	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—IL6—osteoarthritis	0.000309	0.000312	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IGF1—osteoarthritis	0.000308	0.00031	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000306	0.000309	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000306	0.000309	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000305	0.000307	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—IL6—osteoarthritis	0.000305	0.000307	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—IL6—osteoarthritis	0.000305	0.000307	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000302	0.000305	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000299	0.000302	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IGF1—osteoarthritis	0.000298	0.0003	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IGF1—osteoarthritis	0.000298	0.0003	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000286	0.000288	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000285	0.000287	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SMAD3—osteoarthritis	0.000283	0.000285	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000282	0.000284	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MMP3—osteoarthritis	0.000277	0.000279	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000276	0.000278	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000276	0.000278	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LEP—osteoarthritis	0.000276	0.000278	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—BGN—osteoarthritis	0.000273	0.000275	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CXCL8—osteoarthritis	0.000272	0.000274	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MMP3—osteoarthritis	0.000268	0.00027	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MMP3—osteoarthritis	0.000268	0.00027	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000266	0.000268	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP3—osteoarthritis	0.000264	0.000266	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—ESR1—osteoarthritis	0.000263	0.000265	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FN1—osteoarthritis	0.00026	0.000262	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IL6—osteoarthritis	0.000259	0.000261	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—BGN—osteoarthritis	0.000257	0.000259	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000253	0.000255	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000247	0.000248	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LEP—osteoarthritis	0.000242	0.000243	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1A—osteoarthritis	0.000239	0.000241	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SMAD3—osteoarthritis	0.000239	0.000241	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—BMP2—osteoarthritis	0.000236	0.000238	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1A—osteoarthritis	0.000231	0.000233	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1A—osteoarthritis	0.000231	0.000233	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—ESR1—osteoarthritis	0.000231	0.000232	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CXCL8—osteoarthritis	0.00023	0.000231	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—BMP2—osteoarthritis	0.000228	0.00023	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—BMP2—osteoarthritis	0.000228	0.00023	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FN1—osteoarthritis	0.000228	0.00023	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IGF1—osteoarthritis	0.000228	0.000229	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—IL6—osteoarthritis	0.00022	0.000221	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—osteoarthritis	0.000213	0.000214	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—osteoarthritis	0.000213	0.000214	CbGpPWpGaD
Loperamide—CALM3—Disease—SMAD3—osteoarthritis	0.000211	0.000213	CbGpPWpGaD
Loperamide—CALM2—Disease—SMAD3—osteoarthritis	0.000204	0.000206	CbGpPWpGaD
Loperamide—CALM1—Disease—SMAD3—osteoarthritis	0.000204	0.000206	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LEP—osteoarthritis	0.000204	0.000206	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000202	0.000204	CbGpPWpGaD
Loperamide—CALM3—Immune System—CRP—osteoarthritis	0.0002	0.000201	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IGF1—osteoarthritis	0.0002	0.000201	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ESR1—osteoarthritis	0.000195	0.000196	CbGpPWpGaD
Loperamide—CALM2—Immune System—CRP—osteoarthritis	0.000193	0.000195	CbGpPWpGaD
Loperamide—CALM1—Immune System—CRP—osteoarthritis	0.000193	0.000195	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FN1—osteoarthritis	0.000193	0.000194	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—osteoarthritis	0.000185	0.000186	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CXCL8—osteoarthritis	0.000183	0.000184	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—osteoarthritis	0.000179	0.00018	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—osteoarthritis	0.000179	0.00018	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—osteoarthritis	0.000174	0.000175	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000174	0.000175	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1—osteoarthritis	0.000169	0.00017	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—BGN—osteoarthritis	0.000168	0.000169	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—osteoarthritis	0.000166	0.000167	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP3—osteoarthritis	0.000163	0.000165	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CXCL8—osteoarthritis	0.000161	0.000162	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP3—osteoarthritis	0.000158	0.000159	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP3—osteoarthritis	0.000158	0.000159	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—osteoarthritis	0.000153	0.000154	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SMAD3—osteoarthritis	0.000148	0.000149	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—osteoarthritis	0.000145	0.000146	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SMAD3—osteoarthritis	0.000143	0.000144	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SMAD3—osteoarthritis	0.000143	0.000144	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CXCL8—osteoarthritis	0.000142	0.000143	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CXCL8—osteoarthritis	0.000138	0.000139	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CXCL8—osteoarthritis	0.000138	0.000139	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—osteoarthritis	0.000137	0.000138	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CXCL8—osteoarthritis	0.000136	0.000137	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—osteoarthritis	0.000129	0.00013	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—osteoarthritis	0.000126	0.000127	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—osteoarthritis	0.000125	0.000126	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—osteoarthritis	0.000125	0.000126	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—osteoarthritis	0.000124	0.000125	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—osteoarthritis	0.000123	0.000124	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—osteoarthritis	0.000122	0.000123	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—osteoarthritis	0.000122	0.000123	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—osteoarthritis	0.000121	0.000122	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—osteoarthritis	0.000121	0.000122	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ESR1—osteoarthritis	0.000121	0.000122	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—osteoarthritis	0.00012	0.000121	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—osteoarthritis	0.00012	0.000121	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—osteoarthritis	0.00012	0.000121	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FN1—osteoarthritis	0.000119	0.00012	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ESR1—osteoarthritis	0.000117	0.000118	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ESR1—osteoarthritis	0.000117	0.000118	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FN1—osteoarthritis	0.000115	0.000116	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FN1—osteoarthritis	0.000115	0.000116	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—osteoarthritis	0.000106	0.000107	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—osteoarthritis	0.000104	0.000105	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—osteoarthritis	0.000104	0.000104	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—osteoarthritis	0.000103	0.000104	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—osteoarthritis	0.000101	0.000102	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—osteoarthritis	0.000101	0.000102	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—osteoarthritis	0.000101	0.000102	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—osteoarthritis	0.0001	0.000101	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—osteoarthritis	0.0001	0.000101	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—osteoarthritis	9.02e-05	9.09e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—osteoarthritis	9.01e-05	9.08e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—osteoarthritis	8.94e-05	9.01e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—osteoarthritis	8.65e-05	8.72e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—osteoarthritis	8.65e-05	8.72e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—osteoarthritis	8.4e-05	8.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—osteoarthritis	8.13e-05	8.19e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—osteoarthritis	8.13e-05	8.19e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—osteoarthritis	7.99e-05	8.05e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—osteoarthritis	7.85e-05	7.91e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—osteoarthritis	7.73e-05	7.78e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—osteoarthritis	7.73e-05	7.78e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—osteoarthritis	7.62e-05	7.68e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—osteoarthritis	7.6e-05	7.65e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—osteoarthritis	7.4e-05	7.45e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—osteoarthritis	7.35e-05	7.4e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—osteoarthritis	7.35e-05	7.4e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—osteoarthritis	7.3e-05	7.35e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—osteoarthritis	7.06e-05	7.11e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—osteoarthritis	7.06e-05	7.11e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—osteoarthritis	6.74e-05	6.79e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—osteoarthritis	6.52e-05	6.57e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—osteoarthritis	6.52e-05	6.57e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—osteoarthritis	6.26e-05	6.31e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—osteoarthritis	6.06e-05	6.1e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—osteoarthritis	6.06e-05	6.1e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—osteoarthritis	4.84e-05	4.87e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—osteoarthritis	4.72e-05	4.75e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—osteoarthritis	4.56e-05	4.6e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—osteoarthritis	4.56e-05	4.6e-05	CbGpPWpGaD
